BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38868662)

  • 1. Decision aid development and its acceptability among adults with attention-deficit/hyperactivity disorders regarding treatment discontinuation after remission.
    Tsujii N; Okada T; Usami M; Kuwabara H; Fujita J; Negoro H; Iida J; Aoki Y; Takaesu Y; Saito T
    PCN Rep; 2022 Dec; 1(4):e57. PubMed ID: 38868662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission.
    Aoki Y; Takaesu Y; Baba H; Iga JI; Hori H; Inoue T; Mishima K; Tajika A; Kato M
    Neuropsychopharmacol Rep; 2022 Sep; 42(3):306-314. PubMed ID: 35775506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and field testing of a decision aid to facilitate shared decision making for adults newly diagnosed with attention-deficit hyperactivity disorder.
    Aoki Y; Tsuboi T; Takaesu Y; Watanabe K; Nakayama K; Kinoshita Y; Kayama M
    Health Expect; 2022 Feb; 25(1):366-373. PubMed ID: 34856044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.
    Aoki Y; Takaesu Y; Matsui K; Tokumasu T; Tani H; Takekita Y; Kanazawa T; Kishimoto T; Tarutani S; Hashimoto N; Takeuchi H; Mishima K; Inada K
    Neuropsychopharmacol Rep; 2023 Sep; 43(3):391-402. PubMed ID: 37452456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics.
    Aoki Y; Takaesu Y; Suzuki M; Okajima I; Takeshima M; Shimura A; Utsumi T; Kotorii N; Yamashita H; Kuriyama K; Watanabe N; Mishima K
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):10-20. PubMed ID: 34807524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic.
    Aoki Y; Takaesu Y; Inada K; Yamada H; Murao T; Kikuchi T; Takeshima M; Tani M; Mishima K; Otsubo T
    Front Psychiatry; 2023; 14():1083568. PubMed ID: 37252154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Continuing and Discontinuing Medications on Quality of Life After Symptomatic Remission in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.
    Tsujii N; Okada T; Usami M; Kuwabara H; Fujita J; Negoro H; Kawamura M; Iida J; Saito T
    J Clin Psychiatry; 2020 Mar; 81(3):. PubMed ID: 32237294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measure of Caregiver Attention-Deficit/Hyperactivity Disorder Knowledge Is Responsive to Decision Aid on Treatment for Attention-Deficit/Hyperactivity Disorder.
    Valentine KD; Lipstein EA; Vo H; Cosenza C; Barry MJ; Mancini B; Brinkman WB; Sepucha K
    Acad Pediatr; 2024 Apr; 24(3):417-423. PubMed ID: 37536452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliciting preferences for continuing medication among adult patients and parents of children with attention-deficit hyperactivity disorder.
    Khan MU; Balbontin C; Bliemer MCJ; Aslani P
    Health Expect; 2022 Jun; 25(3):1094-1107. PubMed ID: 35266628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.
    Benkert D; Krause KH; Wasem J; Aidelsburger P
    GMS Health Technol Assess; 2010 Sep; 6():Doc13. PubMed ID: 21289886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a decision guide to support the elderly in decision making about location of care: an iterative, user-centered design.
    Garvelink MM; Emond J; Menear M; Brière N; Freitas A; Boland L; Perez MMB; Blair L; Stacey D; Légaré F
    Res Involv Engagem; 2016; 2():26. PubMed ID: 29062524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting parents' and pediatricians' perspectives on shared decision-making in ADHD.
    Fiks AG; Hughes CC; Gafen A; Guevara JP; Barg FK
    Pediatrics; 2011 Jan; 127(1):e188-96. PubMed ID: 21172996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD.
    Maneeton N; Maneeton B; Suttajit S; Reungyos J; Srisurapanont M; Martin SD
    Drug Des Devel Ther; 2014; 8():1685-93. PubMed ID: 25336914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
    Maas L; Raskin N; van Onna M; Cornelissen D; Bours S; van der Weijden T; van den Bergh JP; van Oostwaard M; Wyers CE; Hiligsmann M; Boonen A
    Osteoporos Int; 2024 Jan; 35(1):69-79. PubMed ID: 37733067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared decision-making for people with asthma.
    Kew KM; Malik P; Aniruddhan K; Normansell R
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012330. PubMed ID: 28972652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the feasibility of a decision aid to promote shared decision making among young adults with first-episode psychosis: protocol for a pilot study.
    Zisman-Ilani Y; Hurford I; Bowen A; Salzer M; Thomas EC
    Pilot Feasibility Stud; 2021 Jan; 7(1):22. PubMed ID: 33431018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of a Dutch online decision aid for parents of children with ADHD.
    Ossebaard HC; van Gemert-Pijnen JE; Sorbi MJ; Seydel ER
    J Telemed Telecare; 2010; 16(1):15-9. PubMed ID: 20086262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.